Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liposarcoma | 1 | 2024 | 12 | 0.940 |
Why?
|
| Lipoma | 1 | 2024 | 27 | 0.930 |
Why?
|
| Thymus Neoplasms | 1 | 2024 | 43 | 0.920 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2024 | 2664 | 0.860 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2010 | 689 | 0.480 |
Why?
|
| Aortography | 2 | 2013 | 65 | 0.470 |
Why?
|
| Pulmonary Embolism | 2 | 2018 | 228 | 0.380 |
Why?
|
| Multidetector Computed Tomography | 1 | 2010 | 59 | 0.350 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 89 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2024 | 3453 | 0.320 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 168 | 0.310 |
Why?
|
| Coronary Angiography | 1 | 2008 | 242 | 0.290 |
Why?
|
| Contrast Media | 4 | 2024 | 1092 | 0.280 |
Why?
|
| Heart Atria | 1 | 2008 | 281 | 0.270 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 264 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 364 | 0.240 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2024 | 16 | 0.230 |
Why?
|
| Image Enhancement | 1 | 2007 | 567 | 0.230 |
Why?
|
| Heart Ventricles | 1 | 2008 | 779 | 0.220 |
Why?
|
| Diagnosis, Differential | 4 | 2024 | 1600 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 1247 | 0.220 |
Why?
|
| Tomography | 1 | 2022 | 21 | 0.210 |
Why?
|
| Prostatic Neoplasms | 3 | 2007 | 1772 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 145 | 0.200 |
Why?
|
| Middle Aged | 12 | 2024 | 26040 | 0.190 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 319 | 0.170 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Diaphragm | 1 | 2019 | 50 | 0.170 |
Why?
|
| Esophageal Diseases | 1 | 2019 | 27 | 0.170 |
Why?
|
| Diagnostic Imaging | 3 | 2019 | 479 | 0.160 |
Why?
|
| Humans | 22 | 2024 | 89528 | 0.150 |
Why?
|
| Mechanical Thrombolysis | 1 | 2018 | 16 | 0.150 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 470 | 0.150 |
Why?
|
| Ultrasonic Therapy | 1 | 2018 | 36 | 0.150 |
Why?
|
| Male | 12 | 2024 | 42503 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 217 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 232 | 0.130 |
Why?
|
| Female | 9 | 2024 | 46318 | 0.120 |
Why?
|
| Neoplasms | 2 | 2007 | 3048 | 0.120 |
Why?
|
| Aged | 8 | 2013 | 19213 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2013 | 80 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2013 | 111 | 0.110 |
Why?
|
| Lipomatosis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Hematoma | 1 | 2013 | 108 | 0.110 |
Why?
|
| Adult | 8 | 2024 | 26674 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 2015 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2011 | 59 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2013 | 257 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2010 | 171 | 0.090 |
Why?
|
| Age Distribution | 1 | 2010 | 200 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 360 | 0.090 |
Why?
|
| Prevalence | 2 | 2011 | 1245 | 0.080 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2008 | 2 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2013 | 292 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2011 | 2879 | 0.080 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 12 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2008 | 9 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2011 | 196 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 463 | 0.080 |
Why?
|
| Pyloric Stenosis | 1 | 2006 | 8 | 0.070 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2006 | 6 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 255 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2009 | 497 | 0.070 |
Why?
|
| Gastroscopy | 1 | 2006 | 25 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2008 | 712 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2010 | 9077 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2761 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 200 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 237 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1845 | 0.060 |
Why?
|
| Echocardiography | 1 | 2009 | 938 | 0.060 |
Why?
|
| Prostate | 1 | 2007 | 393 | 0.060 |
Why?
|
| Liver | 1 | 2008 | 1210 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 6827 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2007 | 1098 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2010 | 2306 | 0.050 |
Why?
|
| Subcutaneous Fat | 1 | 2022 | 22 | 0.050 |
Why?
|
| Syndrome | 2 | 2013 | 449 | 0.050 |
Why?
|
| Body Composition | 1 | 2022 | 71 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 77 | 0.050 |
Why?
|
| Prognosis | 1 | 2009 | 3791 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 2365 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 1767 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2022 | 259 | 0.040 |
Why?
|
| Esophagus | 1 | 2019 | 106 | 0.040 |
Why?
|
| Esophagectomy | 1 | 2019 | 92 | 0.040 |
Why?
|
| Digital Rectal Examination | 2 | 2007 | 7 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 150 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2018 | 158 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2007 | 233 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 2 | 2007 | 124 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 146 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 293 | 0.030 |
Why?
|
| Radiography | 2 | 2008 | 809 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 2 | 2007 | 360 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2018 | 428 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 601 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1881 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 94 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2013 | 98 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 1727 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 842 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2011 | 25 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 165 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2011 | 624 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 1672 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 4309 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 6339 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 685 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 5344 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 789 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 2018 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2007 | 36 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 234 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 1136 | 0.020 |
Why?
|
| Air | 1 | 2006 | 62 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1862 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8266 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 684 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 2488 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2350 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 3740 | 0.010 |
Why?
|
| Child | 1 | 2008 | 7188 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 5505 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2284 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 9280 | 0.010 |
Why?
|